Long-term follow-up after endovascular treatment of benign superior vena cava obstructions : P-55
Détails
ID Serval
serval:BIB_42404E0494C8
Type
Actes de conférence (partie): contribution originale à la littérature scientifique, publiée à l'occasion de conférences scientifiques, dans un ouvrage de compte-rendu (proceedings), ou dans l'édition spéciale d'un journal reconnu (conference proceedings).
Sous-type
Abstract (résumé de présentation): article court qui reprend les éléments essentiels présentés à l'occasion d'une conférence scientifique dans un poster ou lors d'une intervention orale.
Collection
Publications
Institution
Titre
Long-term follow-up after endovascular treatment of benign superior vena cava obstructions : P-55
Titre de la conférence
CIRSE 2007, Annual Meeting and Postgraduate Cours of the Cardiovascular and Interventional Radiological Society of Europe
Adresse
Athens, Greece, September 8th - 12th, 2007
Statut éditorial
Publié
Date de publication
2007
Notes
Purpose: To report our clinical experience with endovascular treatment of benign superior vena cava (SVC) obstructions.
Materials/Methods: Sixty-four patients with a mean age of 64 years were treated for benign SVC obstruction. Obstructions were related to implanted central venous catheters, postradiation fibrosis, permanent pacemaker, or benign tumors. Obstructions were confirmed with helical CT or phlebography and classified according to the Stanford's classifications: type I (n=2), type II (n=12), type III (n=27), type IV (n=23). The follow-up ranged between 6 and 92 months.
Results: Recanalization was successful in 63/64 patients (98%). 70 stents were implanted in the 58 patients. 46 patients had one stent and 12 patients had two stents. Stents were placed after percutaneous balloon angioplasty in 26 patients and primary stent placement was attempted in 32 patients. All symptomatic patients had their symptoms relieved completely within 1 week of stent placement. No complications occurred. SVC syndrome recurred in three patients during follow-up and was treated by placing a second stent. The primary assisted patency rate was 100%, 98% and 67% at, respectively, 1, 2 and 5 years.
Conclusion: Stent placement in benign SVC obstructions is a safe and minimally invasive procedure with a high long term assisted patency.
Materials/Methods: Sixty-four patients with a mean age of 64 years were treated for benign SVC obstruction. Obstructions were related to implanted central venous catheters, postradiation fibrosis, permanent pacemaker, or benign tumors. Obstructions were confirmed with helical CT or phlebography and classified according to the Stanford's classifications: type I (n=2), type II (n=12), type III (n=27), type IV (n=23). The follow-up ranged between 6 and 92 months.
Results: Recanalization was successful in 63/64 patients (98%). 70 stents were implanted in the 58 patients. 46 patients had one stent and 12 patients had two stents. Stents were placed after percutaneous balloon angioplasty in 26 patients and primary stent placement was attempted in 32 patients. All symptomatic patients had their symptoms relieved completely within 1 week of stent placement. No complications occurred. SVC syndrome recurred in three patients during follow-up and was treated by placing a second stent. The primary assisted patency rate was 100%, 98% and 67% at, respectively, 1, 2 and 5 years.
Conclusion: Stent placement in benign SVC obstructions is a safe and minimally invasive procedure with a high long term assisted patency.
Création de la notice
09/04/2008 16:17
Dernière modification de la notice
20/08/2019 13:44
Données d'usage
